Hints and tips:
Related Special Reports
...AbbVie and Eli Lilly have withdrawn from the deal after the German conglomerate Bayer’s pharmaceutical chief executive told the Financial Times on Monday that it was reducing its UK footprint and cutting...
...Shares in Vectura, whose clients include GlaxoSmithKline and Hikma Pharmaceuticals, closed up 14 per cent at 155p....
...Another biotech, GL Rapha, will produce doses of Russia’s Sputnik V jab for global use. Additional reporting by Sherry Fei Ju in Beijing...
...Top Indian pharmaceutical companies have tie-ins for local production of other globally approved vaccines, like Russia’s Sputnik V, but regulators want local “bridging studies” to gauge their effectiveness...
...over, and poorer countries whose governments are stretched to secure doses for healthcare workers and the most vulnerable....
...Bayer, the German pharmaceutical group, also said it would donate 3m of its malaria tablets, but as they are not approved in the US, they need an emergency authorisation from the FDA....
...The prospect of much lower bond yields — and, crucially, the expectation that central banks will contain any sharp rise — has encouraged investors to boost their exposure to the technology and healthcare...
...While we’re on the topic of M&A deals gone sour, ears will be burning over at Bayer....
...Speaking in a conference room above New York’s Park Avenue, he described how he and fellow analysts were impressed that sales were taking off, when most small biotech companies spend years investing in R...
...We did this two years ago when Ian Read, the Scottish-born accountant turned businessman, announced his plans to step down as chief executive of pharmaceuticals group Pfizer....
...The pharmaceutical and healthcare sectors have been among the most active with $479bn worth of transactions announced....
...The group’s recent shift to the healthcare and pharmaceutical business follows a pattern of Japanese companies diversifying to offset a chronic decline in the domestic beer market, which peaked 25 years...
...healthcare”, in which technology is leveraged, on-demand, to create medication specific to the individual....
...It was this statement of corporate social responsibility — crafted decades before the term became overused PR — which he said had guided the world’s largest healthcare company to become a solid, long-term...
...It would top the $120m paid to rival Morgan Stanley when it advised on Monsanto’s $66bn sale to Germany’s Bayer in 2016....
...(FT) PE and trailer parks With roughly 1 in 15 Americans living in trailer parks, US private equity firms have come knocking....
...That puts it ahead of its nearest competitors Johnson & Johnson, Sanofi and Bayer, which hold about 4 per cent market shares each....
...A version of this article was first published by the Nikkei Asian Review on July 5, 2019. ©201 Nikkei Inc. All rights reserved....
...Samsung BioLogics is crucial to the long-term strategy of parent Samsung Group as the conglomerate expands into pharmaceuticals and healthcare, looking to drive profits in coming decades as clouds gather...
...“The proximity of our population also helped us design and spread social and economic ideas such as microfinance and low-cost healthcare....
...Diane Parks, Theranos’s chief commercial officer, had twenty-five years of experience at pharmaceutical and biotechnology companies....
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
...Reckitt cited financial discipline for quitting the two-horse race, as it also did in 2014, when it withdrew from bidding for the healthcare unit of Merck of the US, leaving Germany’s Bayer to clinch the...
...This fourth tranche of 30 ideas (listed below) is about the latest advances in healthcare. The fifth and final chapter, looking at Earth and the universe, will be published on March 29, 2018....
...In 2014, Bayer paid seven times sales to German peer Merck in a $14bn deal....
International Edition